Fisher & Paykel Healthcare Corp Ltd
Company Profile
- Business description- Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the US, 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model. 
- Contact- 15 Maurice Paykel Place 
 East Tamaki
 AucklandNTL2013
 NZL- T: +64 95740100 - E: investor@fphcare.co.nz 
- Sector- Healthcare - Stock type- Defensive 
- Industry- Medical Instruments & Supplies - Fiscal Year End- 31 March 2026 - Employees- 7,440 
Fisher & Paykel Healthcare Corp Ltd News & Analysis
stocks
ASX healthcare stocks shrug off new tariff threat
stocks
3 overvalued ASX stocks with cheaper alternatives
stocks
Avoid this overpriced ASX healthcare company
Morningstar Investment Ideas
Markets
| Index | Last price | Change | % Change | 
|---|---|---|---|
| All Ordinaries | 9,205.70 | 1.00 | -0.01% | 
| CAC 40 | 8,157.29 | 43.59 | -0.53% | 
| DAX 40 | 24,118.89 | 5.32 | -0.02% | 
| Dow JONES (US) | 47,522.12 | 109.88 | -0.23% | 
| FTSE 100 | 9,760.06 | 3.92 | 0.04% | 
| HKSE | 26,130.99 | 151.70 | -0.58% | 
| NASDAQ | 23,581.14 | 377.33 | -1.57% | 
| Nikkei 225 | 51,948.26 | 622.65 | 1.21% | 
| NZX 50 Index | 13,551.92 | 92.63 | 0.69% | 
| S&P 500 | 6,822.34 | 68.25 | -0.99% | 
| S&P/ASX 200 | 8,908.40 | 4.80 | -0.05% | 
| SSE Composite Index | 3,966.94 | 19.96 | -0.50% |